University of Liege
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1817-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ulg.ac.be
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 19
- Registration Number
- NCT01903473
- Locations
- 🇧🇪
Katholieke Universiteit Leuven, Leuven, Vlaams-Brabant, Belgium
🇧🇪University Hospital Liège, Liège, Belgium
Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 50
- Registration Number
- NCT01862354
- Locations
- 🇧🇪
University of Liege, University Hospital, Liege, Belgium
Clinical Tolerance of Numeta 13%
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2013-01-21
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 30
- Registration Number
- NCT01772927
- Locations
- 🇧🇪
Department of Neonatology University hospital of Liege, Liege, Belgium
Effects of 3 Months of Controlled Whole Body Vibrations on the Risk of Falls Among Nursing Home Residents
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 62
- Registration Number
- NCT01759680
- Locations
- 🇧🇪
University of Liège, Liège, Belgium
Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-27
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 55
- Registration Number
- NCT01673126
- Locations
- 🇧🇪
University Hospital of Liège, Liège, Belgium
Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-03-06
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 50
- Registration Number
- NCT01544712
- Locations
- 🇧🇪
University of Liège, Liège, Belgium
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
- First Posted Date
- 2012-02-28
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 13
- Registration Number
- NCT01540292
- Locations
- 🇧🇪
University Hospital Liège, Liège, Belgium
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 200
- Registration Number
- NCT01428973
- Locations
- 🇧🇪
AZ VUB Jette, Brussels, Brussels Region Capital, Belgium
🇧🇪Jolimont Hospital Haine Saint Paul, Haine St-Paul, Hainaut, Belgium
🇧🇪Jules Bordet Institute, Brussels, Brabant, Belgium
Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- University of Liege
- Registration Number
- NCT01429012
- Locations
- 🇧🇪
Liège University Hospital, Liège, Belgium
Mesenchymal Stem Cells After Renal or Liver Transplantation
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-05
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 40
- Registration Number
- NCT01429038
- Locations
- 🇧🇪
University Hospital Liege, Liege, Belgium
© Copyright 2024. All Rights Reserved by MedPath